Standard

Russian pharmaceutical companies : Business models of market leaders. / Kravchenko, Nataliya A.; Yusupova, Almira T.

In: Voprosy Ekonomiki, Vol. 2019, No. 8, 08.2019, p. 127-138.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Kravchenko NA, Yusupova AT. Russian pharmaceutical companies: Business models of market leaders. Voprosy Ekonomiki. 2019 Aug;2019(8):127-138. doi: 10.32609/0042-8736-2019-8-127-138

Author

BibTeX

@article{25a3cf41034b4a859f4f10c3556f03aa,
title = "Russian pharmaceutical companies: Business models of market leaders",
abstract = "Many factors influence firms{\textquoteright} growth possibilities and market positions. This paper deals with business models as company{\textquoteright}s competitiveness determinant; the case of Russian leading pharmaceutical companies is studied. The review of global pharmaceutical leaders{\textquoteright} business models is presented. Russian leaders are indentified basing on empirical data provided by SPARK database. It has been found that they use models of disruptive research, models aimed at business value growth as well as models of active portfolio management. Characteristics and perspectives of each model type are determined.",
keywords = "Business models, Pharmaceutical industry, Russian leading companies, business models, pharmaceutical industry",
author = "Kravchenko, {Nataliya A.} and Yusupova, {Almira T.}",
year = "2019",
month = aug,
doi = "10.32609/0042-8736-2019-8-127-138",
language = "English",
volume = "2019",
pages = "127--138",
journal = "Voprosy Ekonomiki",
issn = "0042-8736",
publisher = "Voprosy Ekonomiki",
number = "8",

}

RIS

TY - JOUR

T1 - Russian pharmaceutical companies

T2 - Business models of market leaders

AU - Kravchenko, Nataliya A.

AU - Yusupova, Almira T.

PY - 2019/8

Y1 - 2019/8

N2 - Many factors influence firms’ growth possibilities and market positions. This paper deals with business models as company’s competitiveness determinant; the case of Russian leading pharmaceutical companies is studied. The review of global pharmaceutical leaders’ business models is presented. Russian leaders are indentified basing on empirical data provided by SPARK database. It has been found that they use models of disruptive research, models aimed at business value growth as well as models of active portfolio management. Characteristics and perspectives of each model type are determined.

AB - Many factors influence firms’ growth possibilities and market positions. This paper deals with business models as company’s competitiveness determinant; the case of Russian leading pharmaceutical companies is studied. The review of global pharmaceutical leaders’ business models is presented. Russian leaders are indentified basing on empirical data provided by SPARK database. It has been found that they use models of disruptive research, models aimed at business value growth as well as models of active portfolio management. Characteristics and perspectives of each model type are determined.

KW - Business models

KW - Pharmaceutical industry

KW - Russian leading companies

KW - business models

KW - pharmaceutical industry

UR - http://www.scopus.com/inward/record.url?scp=85073384479&partnerID=8YFLogxK

U2 - 10.32609/0042-8736-2019-8-127-138

DO - 10.32609/0042-8736-2019-8-127-138

M3 - Article

AN - SCOPUS:85073384479

VL - 2019

SP - 127

EP - 138

JO - Voprosy Ekonomiki

JF - Voprosy Ekonomiki

SN - 0042-8736

IS - 8

ER -

ID: 21903016